New research reveals that cognitive deterioration, particularly in processing speed, can begin up to eight years before the onset of cardiovascular disease in older adults, offering a potential new window for clinical intervention.
A pioneering study published in the journal JAMA Network Open has unveiled a critical timeline regarding the relationship between cardiovascular health and cognitive function in older adults. By analyzing an extensive 11-year dataset derived from the Aspirin in Reducing Events in the Elderly (ASPREE) trial and its extension, ASPREE-XT, researchers have identified a significant pattern of cognitive deterioration that often precedes a clinical cardiovascular disease (CVD) event.
This research involved over 19,000 initially healthy participants aged 70 and older, providing a robust foundation for understanding how the brain and heart interact long before the onset of overt cardiac illness. The findings suggest that the brain may serve as an early warning system, with specific cognitive markers signaling an underlying cardiovascular risk years before a heart attack, stroke, or heart failure occurs. The research methodology focused on comparing individuals who eventually experienced a cardiovascular event with a matched control group. Through the application of advanced mixed-effects statistical models, the study tracked cognitive performance across several key domains, including processing speed, verbal fluency, episodic memory, and global cognition. The results revealed that those destined to experience a CVD event exhibited a marked acceleration in cognitive decline compared to their healthy counterparts. Most notably, processing speed—the ability to take in information and respond to it efficiently—began to deteriorate as early as eight years before the clinical diagnosis of a cardiovascular issue. This was followed by progressive declines in episodic memory and global cognition about five years prior to the event, while verbal fluency began to wane approximately three years before the onset. These findings challenge the traditional belief that cognitive issues are merely a secondary consequence of cardiovascular damage, suggesting instead a more complex, bidirectional decline that begins in the subclinical stages of disease progression. This study holds profound implications for clinical practice and preventive medicine. By recognizing that cognitive changes often precede cardiovascular events, healthcare providers could potentially implement cognitive screening as a tool to identify high-risk individuals before a major cardiac crisis occurs. The consistency of these patterns across different types of cardiovascular events, including stroke and heart failure, underscores the systemic nature of vascular and cognitive health. While the study noted that certain trajectories were steeper in female participants and those with existing comorbidities like hypertension or chronic kidney disease, the fundamental link between early cognitive shifts and future cardiac events remained clear across the diverse study population. This research not only fills a significant gap in the current understanding of geriatric health but also opens new avenues for personalized preventive strategies, where monitoring cognitive health may play a pivotal role in mitigating the risks associated with cardiovascular decline in an aging global population
Cognitive Decline Cardiovascular Disease Geriatric Health Processing Speed ASPREE Study
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Roberto de Zerbi's Tottenham assessment a warning to Leeds United and rivals in drop fightSpurs remain in the relegation zone but are bullish about surviving
Read more »
State Pension, Universal Credit and other benefits to be paid early for some people next weekFull list of DWP, HMRC and Social Security Scotland payments which might arrive early due to bank holidays in May.
Read more »
Warning of three-metre high tsunami after 7.4-magnitude earthquake hits JapanA 7.4-magnitude earthquake has struck off the coast of Japan, sparking warnings of tsunami waves as high as 3 metres.
Read more »
Exercise and ibuprofen help reduce cognitive impairment during chemotherapyUp to 80% of people who receive chemotherapy experience cancer-related cognitive impairment, which most commonly involves mild-to-moderate changes such as difficulty paying attention, memory lapses, and struggles with multitasking.
Read more »
– Preston woman opens up on life with MS, symptoms and the slow declineSuzanne Juniper says seeking help from The MS Society has changed how she now views having multiple scelerosis
Read more »
Ibuprofen shown to improve cognitive function in patients undergoing chemotherapyResearchers have already shown that mild to moderate exercise can reduce 'chemo brain,' and a new study suggests that a low dose of an over-the-counter anti-inflammatory, ibuprofen, can also achieve positive results for cancer patients.
Read more »